Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  gallium Ga 68-DOTATATE
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-10 of 10 for your search:
Start Over
Randomized Phase III of PRRT Versus Interferon
Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: IJBMNCASTOR, 2012-005545-20, NCT01860742
68-Ga-DOTATATE PET-CT Scan for Diagnosis and Staging of Neuroendocrine Tumors
Phase: Phase II, Phase I
Type: Diagnostic
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: 117289, NCT01879657
68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors
Phase: Phase II, Phase I
Type: Diagnostic
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 68Ga-DOTATATE, NCT02038738
Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors
Phase: Phase II, Phase I
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 092/11, NCT02078843
Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors
Phase: Phase II
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 130193, 13-C-0193, NCT01967537
68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: PUMCHNM001, NCT01524016
Safety and Efficacy of 68Ga-DOTA-tyr3-Octreotide
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 2 and over
Sponsor: Other
Protocol IDs: 201110718, 114398, NCT01619865
Evaluation of PET-CT Using Somatostatin Agonists Labeled With Gallium68 in Neuroendocrine Tumors
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2013-27, NCT02150408
68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs)
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GCO 14-2008, NCT02359500
Comparison of Diagnostic Performances of 68Ga-DOTATATE PET-CT and 18F-FDOPA PET-CT in Paragangliomas and Pheochromocytomas Evaluation
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2013-26, NCT02186678
Start Over